Novo’s workforce reduction climbs to 13,000 to fuel R&D work
Novo CEO Maziar Mike Doustdar disclosed an additional 4,000 staff departures, which a spokesperson told BioSpace are linked to attrition and other measures.
Read the full article on the original site.
Read Full Article